PHASE 2 CLINICAL TRIALS OF OLTIPRAZ IN BREAST NEOPLASIA WORKSTATEMENT -261965001

$0N01FY2002CANIH

Georgetown University, Washington DC

Investigators

View original record on NIH RePORTER →